PubMed=7989126; DOI=10.1002/ijc.2910590621
Helga Bernhard, Julia Karbach, Thomas Wolfel, Petra Busch, Stefan Storkel, Michael Stockle, Catherine Wolfel, Barbara Seliger, Christoph Huber, Karl-Hermann Meyer zum Buschenfelde, Alexander Knuth;
Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Int. J. Cancer 59:837-842(1994)

PubMed=9816317
Barbara Seliger, Alexandra Hohne, Alexander Knuth, Helga Bernhard, Bettina Ehring, Robert Tampe, Christoph Huber;
Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Clin. Cancer Res. 2:1427-1433(1996)

PubMed=12833523; DOI=10.1002/pmic.200300404
Barbara Seliger, Matthias Menig, Rudolf Lichtenfels, Derek Atkins, Jurgen H. Bukur, Thomas M. Halder, Michael Kersten, Alois Harder, Angelika Ackermann, Joachim Beck, Bernd Muehlenweg ...Show all 15 authors... , Walburgis Brenner, Sebastian Melchior, Roland Kellner, Friedrich Lottspeich; Show fewer authors
Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.
Proteomics 3:979-990(2003)

CLPUB00420
Jurgen H. Bukur;
Characterization of T cell responses against human renal cell carcinoma and identification of HLA-G as a tumor-associated antigen and immune evasion mechanism of renal cell carcinoma.
Thesis PhD (2004); Johannes Gutenberg University Mainz; Mainz; Germany

PubMed=17200335; DOI=10.1158/1078-0432.CCR-06-0824
Barbara Seliger, Alla Fedorushchenko, Walburgis Brenner, Angelika Ackermann, Derek Atkins, Samir M. Hanash, Rudolf Lichtenfels;
Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.
Clin. Cancer Res. 13:27-37(2007)

PubMed=23696916; PMCID=PMC3657351
Christine G. Stoehr, Maike Buettner-Herold, Esther Kamphausen, Simone Bertz, Arndt Hartmann, Barbara Seliger;
Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.
Int. J. Clin. Exp. Pathol. 6:998-1008(2013)